Skip to main content

Table 1 Socio-demographic and clinical characteristics of 336 patients with COVID-19 and the association with PTSD and depressive symptoms

From: The impact of isolation on comorbidity of PTSD symptoms and depression: evidence from PTRP-5-6 in China

 

Total (n = 336)

With PTSD symptoms

p-value

 

With Depressive symptoms

p-value

N

%

N

%

 

N

%

Socio-demographic characteristics

         

 Gender

         

  Male

252

75.0

10

4.0

0.008**

 

69

27.4

0.064

  Female

84

25.0

10

11.9

  

32

38.1

 

 Age

         

  18–24

53

15.8

3

5.7

0.746

 

22

41.5

0.118

  25–44

193

57.4

13

6.7

  

56

29.0

 

  ≥ 45

90

26.8

4

4.4

  

23

25.6

 

 BMI, Kg/m2

         

  ≤ 18.5

16

4.8

1

6.3

0.852

 

6

37.5

0.085

  18.5–24.9

207

61.8

11

5.3

  

70

33.8

 

  25-29.9

92

27.5

6

6.5

  

21

22.8

 

  ≥ 30

20

6.0

2

10.0

  

3

15.0

 

 Marital status

         

  Single

132

39.3

6

4.5

0.312

 

47

35.6

0.196

  Married

187

55.7

14

7.5

  

49

26.2

 

  Others

17

5.1

0

0.0

  

5

29.4

 

 Educational level

         

  Below undergraduate

270

80.4

17

6.3

0.819

 

75

27.8

0.044*

  Undergraduate

50

14.9

2

4.0

  

17

34.0

 

  Master or above

16

4.8

1

6.3

  

9

56.3

 

 Family member infected with COVID-19

        

  No

248

73.8

11

4.4

0.049*

 

74

29.8

0.882

  Yes

88

26.2

9

10.2

  

27

30.7

 

Clinical characteristics

         

 Symptoms at onset

         

  Sore throat

         

   No

209

62.2

13

6.2

0.790

 

50

23.9

0.002**

   Yes

127

37.8

7

5.5

  

51

40.2

 

  Dry throat

         

   No

171

50.9

9

5.3

0.587

 

41

24.0

0.882

   Yes

165

49.1

11

6.7

  

60

36.4

 

  Cough

         

   No

137

40.8

8

5.8

0.942

 

29

21.2

0.003**

   Yes

199

59.2

12

6.0

  

72

36.2

 

  Dyspnea

         

   No

315

93.8

17

5.4

0.096

 

91

28.9

0.070

   Yes

21

6.3

3

14.3

  

10

47.6

 

  Fever

         

   No

240

71.4

15

6.3

0.715

 

59

24.6

0.001**

   Yes

96

28.6

5

5.2

  

42

43.8

 

  Fatigue

         

   No

240

71.4

15

6.3

0.715

 

56

23.3

< 0.001***

   Yes

96

28.6

5

5.2

  

45

46.9

 

  Dizziness or Headache

         

   No

247

73.5

15

6.1

0.876

 

55

22.3

< 0.001***

   Yes

89

26.5

5

5.6

  

46

51.7

 

  Gastrointestinal symptoms

         

   No

302

89.9

15

5.0

0.023*

 

82

27.2

0.001***

   Yes

34

10.1

5

14.7

  

19

55.9

 

  Loss of appetite

         

   No

276

82.1

14

5.1

0.144

 

70

25.4

< 0.001***

   Yes

60

17.9

6

10.0

  

31

51.7

 

  Loss of taste or dysgeusia

         

   No

308

91.7

19

6.2

0.578

 

89

28.9

0.123

   Yes

28

8.3

1

3.6

  

12

42.9

 

  Loss of smell or dysosmia

         

   No

310

92.3

19

6.1

0.637

 

89

28.7

0.062

   Yes

26

7.7

1

3.8

  

12

46.2

 

  Hair loss

         

   No

311

92.6

18

5.8

0.653

 

94

30.2

0.815

   Yes

25

7.4

2

8.0

  

7

28.0

 

  Others

         

   No

322

95.8

17

5.3

0.012*

 

95

29.5

0.286

   Yes

14

4.2

3

21.4

  

6

42.9

 

 Underlying disease

         

  Hypertension

         

   No

305

90.8

17

5.6

0.358

 

90

29.5

0.489

   Yes

31

9.2

3

9.7

  

11

35.5

 

  Diabetes

         

   No

329

97.9

20

6.1

0.501

 

98

29.8

0.456

   Yes

7

2.1

0

0.0

  

3

42.9

 

  COPD

         

   No

332

98.8

20

6.0

0.613

 

98

29.5

0.155

   Yes

4

1.2

0

0.0

  

3

75.0

 

  Coronary disease

         

   No

327

97.3

20

6.1

0.444

 

98

30.0

0.828

   Yes

9

2.7

0

0.0

  

3

33.3

 

  Others

         

   No

323

96.1

20

6.2

0.355

 

96

29.7

0.500

   Yes

13

3.9

0

0.0

  

5

38.5

 
  1. Note: P-value were derived from the chi-square test of the variable and PTSD /depressive symptoms.*, p-value < 0.05; **, p-value < 0.01; ***, p-value < 0.001